(Q53933482)

22 May 2018

title

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. (English)

1 reference

22 May 2018

main subject

liver transplantation

1 reference

1 reference

1 reference

9

1 reference

22 May 2018

author name string

Perrillo R

1

1 reference

22 May 2018

Rakela J

2

1 reference

22 May 2018

Dienstag J

3

1 reference

22 May 2018

Levy G

4

1 reference

22 May 2018

Martin P

5

1 reference

22 May 2018

Wright T

6

1 reference

22 May 2018

Caldwell S

7

1 reference

22 May 2018

Schiff E

8

1 reference

22 May 2018

Villeneuve JP

10

1 reference

22 May 2018

Farr G

11

1 reference

22 May 2018

Anschuetz G

12

1 reference

22 May 2018

Crowther L

13

1 reference

22 May 2018

Brown N

14

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

22 May 2018

published in

Hepatology

1 reference

22 May 2018

volume

29

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

1581-1586

1 reference

22 May 2018

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

"Occult" hepatitis B virus as source of infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Liver transplantation and hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Hepatitis B virus DNA contains a glucocorticoid-responsive element

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Interferon in the management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Interferon alfa for recurrent hepatitis B infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Hepatitis B virus immunopathology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290507

7 January 2021

Identifiers

DOI

10.1002/HEP.510290507

1 reference

22 May 2018

PubMed ID

10216146

1 reference

22 May 2018